Bullish & Foolish
Full TLPH fundamentals All 466 on the Survival Watch

TLPHTALPHERA, INC.

Is Talphera struggling financially?

Yes, by its own account. Talphera told the SEC on 13 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

20/100

Fragile

Sector
Biotech/Pharma
Market cap
$61.8M
Source filing
10-Q 13 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 7months

    If the burn speeds up

    Empty by Jan 2027

  • 11months

    If it eases off

    Empty by May 2027

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$17.1M

÷

Cash burned over the last 12 months

$22.1M

What Talphera told the SEC

…from operating activities since inception and expects to continue to incur operating losses and negative cash flows in the future. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Considering the Company’s current cash resources and its current and expected levels of operating expenses for the next twelve months, management expects to need additional capital to…

TALPHERA, INC., Form 10-Q, filed 13 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 138.9% share-count increase The company issued stock. Each share now owns 58.1% less of the business than a year ago, before any change in the price.

Other Biotech/Pharma companies that filed the doubt